Is Dihexa FDA approved?
No. This profile records Dihexa as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE MEMORY AMPLIFIER
DiHexa; PNB-0408; N-hexanoic-Tyr-Ile-(6)-amino-hexanoic amide
Dihexa is a synthetic peptide derived from angiotensin IV that's shown unusually strong synapse-forming activity in preclinical studies. It activates the HGF/c-Met pathway, the same system that helps your brain repair itself, and does so millions of times more potently than BDNF. It promotes new synapse formation and may help with Alzheimer's and Parkinson's.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Dihexa as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 10-20 mg daily (oral or transdermal).
Schedule: daily. Cycle: 6 weeks on, 6 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Powerfully activates brain growth and repair pathways
Promotes formation of new brain connections
Reduces neuroinflammation and microglial overactivation
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.